en · de · es · pt
thymosin-alpha-1-notes.peptides3626.com › Guide › Background And Molecular Identity — Hands-On Walkthrough

Background And Molecular Identity — Hands-On Walkthrough

By Editorial Desk · published 2025-07-01 · last reviewed 2025-08-11 · Guide

thymosin alpha 1 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2025-08-11. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Molecular Identity

The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.

Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.

Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.

Molecular Background and Identity

Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.

Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.

Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular massAbout 3.1 kDa28 residues, N-terminally acetylated
AppearanceWhite to off-white powderLyophilized solid
SolubilityFreely soluble in waterAlso soluble in aqueous buffers
Storage temperature2 to 8 °CProtect from light and moisture
Common synonymsThymalfasin; Tα1Same peptide sequence

Background and Molecular Profile

The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.

The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.

Related pages on this site

Background and Mechanism of Action

Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.

Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.

Handling, Storage, and Analytical Verification

Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.

Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.

Further detail

The US and Britain merged their western German occupation zones into "Bizone" (1 January 1947, later "Trizone" with the addition of France's zone, April 1949). As part of the economic rebuilding of Germany, in early 1948, representatives of a number of Western European governments and the United States announced an agreement for a merger of western German areas into a federal governmental system. In addition, in accordance with the Marshall Plan, they began to re-industrialize and rebuild the West German economy, including the introduction of a new Deutsche Mark currency to replace the old Reichsmark currency that the Soviets had debased. The US had secretly decided that a unified and neutral Germany was undesirable, with Walter Bedell Smith telling General Eisenhower "in spite of our announced position, we really do not want nor intend to accept German unification on any terms that the Russians might agree to, even though they seem to meet most of our requirements." Shortly thereafter, Stalin instituted the Berlin Blockade (June 1948 – May 1949), one of the first major crises of the Cold War, preventing Western supplies from reaching West Germany's enclave of West Berlin. The United States (primarily), Britain, France, Canada, Australia, New Zealand, and several other countries began the massive "Berlin airlift", supplying West Berlin with provisions despite Soviet threats. The Soviets mounted a public relations campaign against the policy change.

I am ordering all carriers, including FedEx, Amazon, UPS and the Post Office, to search for and refuse all deliveries of fentanyl from China (or anywhere else!). Fentanyl kills 100,000 Americans a year. President Xi said this would stop – it didn't.

=== Effects on drug metabolism and drug interactions === The enzymes that are defective in GS – UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) – are also responsible for some of the liver's ability to detoxify certain drugs. For example, Gilbert syndrome is associated with severe diarrhea and neutropenia in patients who are treated with irinotecan, which is metabolized by UGT1A1. While paracetamol (acetaminophen) is not metabolized by UGT1A1, it is metabolized by one of the other enzymes also deficient in some people with GS. A subset of people with GS may have an increased risk of paracetamol toxicity. Another drug that has increased adverse side-effects in individuals with Gilbert syndrome is atazanavir. Atazanavir is a protease inhibitor for the treatment of HIV. Atazanavir can lead to jaundice in individuals with Gilbert syndrome because it further inhibits the UGT enzymes that already exhibit decreased activity in Gilbert syndrome.

The most common set of catabolic reactions in animals can be separated into three main stages. In the first stage, large organic molecules, such as proteins, polysaccharides or lipids, are digested into their smaller components outside cells. Next, these smaller molecules are taken up by cells and converted to smaller molecules, usually acetyl coenzyme A (acetyl-CoA), which releases some energy. Finally, the acetyl group on acetyl-CoA is oxidized to water and carbon dioxide during the citric acid cycle and electron transport chain, releasing more energy while reducing the coenzyme nicotinamide adenine dinucleotide (NAD+) into NADH.

==== Bromantane ==== Bromantane is a stimulant drug with anxiolytic properties developed in Russia during the late 1980s. Bromantane acts mainly by facilitating the biosynthesis of dopamine, through indirect genomic upregulation of relevant enzymes (tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AAAD)).

Sources: en.wikipedia.org

Supporting material

(death announced on this date) 14 October – Rosalind Howells, Baroness Howells of St Davids, 94, British politician, member of the House of Lords (1999–2019). 20 October – Oliver Colvile, 66, British politician, MP (2010–2017). 25 October – Dick Taverne, 97, British politician, MP (1962–1974) and member of the House of Lords (1996–2025). 3 November – John Marshall, 85, British politician, MEP (1979–1989) and MP (1987–1997). 11 November – Helen Newlove, Baroness Newlove, 63, British community reform activist, member of the House of Lords (since 2010). 16 November – Mark Fisher, 81, British politician, minister for the arts (1997–1998) and MP (1983–2010). 17 November – David Pryce-Jones, 89, British conservative commentator, author and historian. 27 November – Peter Whittle, 64, British politician, member of the London Assembly (2016–2021), cancer. 28 November – Sir John Stanley, 83, British politician, MP (1974–2015). 8 December – Kate Allsop, 71, British politician, mayor of Mansfield (2015–2019). (death announced on this date) 17 December – Sir Patrick McNair-Wilson, 96, English politician, MP (1964–1966, 1968–1997). (death announced on this date) 30 December – Joe Byrne, 72, Northern Ireland politician, MLA (1998–2003, 2011–2015). 31 December – Mary Bradley, 83, Northern Irish politician, MLA (2003–2011). (death announced on this date)

=== Predisposing conditions === While most cases of NAION have no known cause, it has been frequently linked to certain conditions. These include general surgical procedures, cataract surgery, hemorrhagic shock, certain medications, and optic disc drusen. The exact mechanism of optic nerve ischemia in these cases remains unclear, but contributing factors may include hypotension, anemia, hypoxia, and changes in the autoregulation of optic nerve arterial blood flow. The incidence of ischemic optic neuropathy leading to vision loss following general surgeries ranges between 0.1% and 0.002%.

In the final step of the biosynthesis, two molecules of 6,7-dimethyl-8-ribityllumazine are combined by the enzyme riboflavin synthase in a dismutation reaction. This generates one molecule of riboflavin and one of 5-amino-6-(D-ribitylamino) uracil. The latter is recycled to the previous reaction in the sequence.

Defending against a full Russian or Chinese attack would require hundreds of thousands of satellites," according to MIT physicists Lisbeth Gronlund and David Wright. The cost of launching satellites is expected to decrease when the heavy-lift SpaceX Starship launch vehicle enters service. Still, the extreme expense of creating such a constellation—and replacing satellites as their orbits decay—has led the U.S. military to also pursue space-based midcourse options that would require fewer satellites. But these would be more expensive and no better than ground-based interceptors at telling decoys from warheads. Space-based interceptors would be guided by the nascent Hypersonic and Ballistic Tracking Space Sensor system, one of the tracking elements of the Space Development Agency's (SDA) seven-layer Proliferated Warfighter Space Architecture (PWSA). The Golden Dome would also be aimed at detecting and countering strikes delivered from a fractional orbital bombardment system (FOBS). Pentagon leaders have said the system could be used to put offensive weapons in space, giving a global strike capability that would create offensive overmatch. Defense Secretary Pete Hegseth has said the U.S. "will be able to strike anywhere, anytime". Satellites might carry the bunker-busting Common-Hypersonic Glide Body (C-HGB), which can reportedly fly 1,000 miles to strike within 14 inches of its target. The missile was designed to fit the HIMARS ground launcher, so several can be compactly racked in a satellite payload bays.

Sources: en.wikipedia.org

Supporting material

=== Discontinuation === The British National Formulary recommends a gradual withdrawal when discontinuing antipsychotic treatment to avoid acute withdrawal syndrome or rapid relapse. In 2021, news reports described the death of a 24‑year‑old California woman, Casandra "Casi" Pastora from Chino Hills, who developed severe rebound psychosis after abruptly discontinuing risperidone and died following a confrontation with police and detention at the West Valley Detention Center in Rancho Cucamonga. Her father's attorney, Ed Lyman, stated: "I think it speaks for itself they [the San Bernardino County Sheriff's Department] knew she [Pastora] was mentally ill. They knew she was pregnant. They knew she was withdrawing from her medication and had medical needs right then and there. They could have taken her to a hospital, but they immediately detained her. In that period, she lost her baby and she lost her life."

14 March Members of the NASUWT narrowly vote to accept a pay offer, ending the prospect of further strike action in schools in Scotland. BBC Scotland hosts the final televised debate of the SNP leadership election. 16 March – Scientists identify a gene variant that is known to increases the risk of breast and ovarian cancer, and trace it to people with Orkney Island heritage, more specifically those with ancestry on the island of Westray. 18 March – Peter Murrell resigns as chief executive of the Scottish National Party amid a row over party membership. Mike Russell succeeds him as interim chief executive. 21 March – At 8pm, Times Radio airs a leadership debate from Edinburgh and featuring the three candidates in the Scottish National Party leadership election. 22 March First Minister Nicola Sturgeon issues a "sincere, heartfelt and unreserved" apology to people affected by the practice of forced adoption in Scotland during the 1950s, 1960s and 1970s. A major incident is declared, with 35 injuries reported, after the 76m-long RV Petrel research vessel tips over at a dock in Leith. 23 March Nicola Sturgeon attends her final First Minister's Questions as First Minister of Scotland. The TikTok app is banned on all Scottish Government phones and electronic devices. 24 March – Research led by the University of Edinburgh suggests one in 50 people in Scotland have had lasting ill-effects after contracting COVID-19. 25 March – HIV Scotland announces it will close due to issues with governance and financials.

== Efficiency == The main limitation in the use of MLC is the reduction in efficiency (peak broadening) that is observed when purely aqueous micellar mobile phases are used. Several explanations for the poor efficiency have been theorized. Poor wetting of the stationary phase by the micellar aqueous mobile phase, slow mass transfer between the micelles and the stationary phase, and poor mass transfer within the stationary phase have all been postulated as possible causes. To enhance efficiency, the most common approaches have been the addition of small amounts of isopropyl alcohol and increase in temperature. A review by Berthod studied the combined theories presented above and applied the Knox equation to independently determine the cause of the reduced efficiency. The Knox equation is commonly used in HPLC to describe the different contributions to overall band broadening of a solute. The Knox equation is expressed as:

Sources: en.wikipedia.org

Frequently asked questions

What is thymosin alpha-1?

It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.

Where does the name come from?

The name traces back to thymosin fraction 5, a crude thymus extract examined in the 1970s. Individual peptides in that mixture were labeled with Greek letters, and alpha-1 was one of them. The international nonproprietary name thymalfasin was assigned later.

Is it the same as thymosin beta-4?

No. Thymosin beta-4 contains 43 residues and binds actin, while thymosin alpha-1 contains 28 residues and acts on immune cells. The two sit in a historical naming group but share no sequence similarity, and they are not substitutes for one another.

Is thymosin alpha 1 a hormone?

The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.

Network